- Prothena Corporation plc shares traded below their 200 - day moving average of $9.37, reaching a low of $8.58 and closing at $8.71.
- The biotechnology company reported second - quarter earnings with an EPS of ($0.32) and revenue of $1.01 million, beating analyst estimates.
- Market analysts maintain a consensus rating of Moderate Buy with a target price of $23.75, amid recent insider transactions and institutional trading activity.